Related Experiment Video
Updated: Jan 31, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Design of randomized controlled confirmatory trials using historical control data to augment sample size for
Jiacheng Yuan1, Jeen Liu1, Ray Zhu1
1a Biostatistics , Allergan Inc , Irvine , CA , USA.
This study introduces a new method to improve clinical trial efficiency by using historical data alongside concurrent controls. The proposed approach enhances sample size savings in randomized controlled trials.
Area of Science:
- Biostatistics
- Clinical Trials
- Epidemiology
Background:
- Augmenting concurrent controls (CC) in randomized controlled trials (RCTs) with historical data is crucial for clinical study efficiency.
- Existing methods, like Stuart and Rubin's matching approach, may not sufficiently save sample sizes when historical data is used as a secondary control group.
Purpose of the Study:
- To propose a novel matching method for RCTs that effectively utilizes historical data to save sample size.
- To introduce a two-stage design for validating the proposed matching method's assumptions before full implementation.
Main Methods:
- A new propensity score estimation technique is developed, excluding concurrent randomized control patients to maximize sample size savings.
- A two-stage adaptive design is proposed to assess the validity of the new matching method.
- The proposed methods are illustrated using previous clinical trial data and validated through simulation studies.
Main Results:
- The novel matching method demonstrates potential for significant sample size reduction in RCTs augmented with historical data.
- Simulation studies confirm the operating characteristics and feasibility of the proposed approach.
- The two-stage design provides a framework for reliable implementation of the sample-saving method.
Conclusions:
- The proposed matching method offers an effective strategy for augmenting concurrent controls with historical data, leading to improved sample size efficiency in clinical trials.
- The two-stage design ensures the robustness and applicability of the method in real-world clinical research settings.
Related Concept Videos
PD Controller: Design
Designing a continuous-data controller requires selecting and linking components like adders and integrators, which are fundamental in Proportional,...
PI Controller: Design
Precipitate Formation and Particle Size Control
The obtained precipitate should be either a pure substance of known composition or easily converted to one by a simple process, such as ignition or drying. In addition, the precipitate should be insoluble and easily filterable. In general, filterability...
Control System Problem
When forming a closed-loop system, issues can arise if the poles cross into the unstable region, leading to potential...
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

